Zheng Cui

Associate Professor of Pathology, Wake Forest University

Zheng Cui, MD PhD, is a biochemist currently serving as an Associate Professor of Pathology (Tumor Biology) at Wake Forest University. Last year his research into granulocyte therapy made headlines throughout anti-aging communities by achieving a complete cure for all types of cancer tested in mice. As an oncologist and a cancer researcher he has proposed that certain individuals (estimated at 10% to 15% of the human population) naturally produce a special kind of white blood cell that contains an inherent resistance to cancer. These white blood cells could potentially be extracted from donors and given to cancer victims, thus endowing them with cancer resistance. Dr. Cui is proposing experimentation of the technique on human subjects. He presented his research findings at the Aging 08 conference in Los Angeles, hosted by the Methuselah Foundation.

video


Natural Cancer Resistance in Mice and in Humans: basis for a novel cancer therapy.

transcript

06.28.08. Understanding Aging: Biomedical and Bioengineering Approaches, Natural Cancer Resistance in Mice and in Humans

video

2007. SENS 3, From a newly discovered innate anticancer immune response in mice to a new treatment for human cancers